Concepedia

Catherine Wang

CW

Statistics

Publications

4

Citations

93

H-Index

4

Active since

2013

Affiliations

GlaxoSmithKline (United States)(Current)

Catherine Wang is an author at GlaxoSmithKline (United States) specializing in oncology, monoclonal antibodies, and life sciences.

Publications per year

2013–2019

4

Publications

4

False-positive immunogenicity responses are caused by CD20+ B cell membrane fragments in an anti-ofatumumab antibody bridging assay

Keguan Chen, Jerry G. Page, Ann Schwartz et al. · Journal of Immunological Methods · 2013 · 33 citations

Life Sciences, Immunology, Oncology +14

First in Human Study with GSK2857916, an Antibody Drug Conjugated to Microtubule-Disrupting Agent Directed Against B-Cell Maturation Antigen (BCMA) in Patients with Relapsed/Refractory Multiple Myeloma (MM): Results from Study BMA117159 Part 1 Dose Escalation

Adam D. Cohen, Rakesh Popat, Suzanne Trudel et al. · Blood · 2016 · 26 citations

Medicine, Oncology, Pharmacology +17

Development of an enzymatic assay for the detection of neutralizing antibodies against therapeutic angiotensin-converting enzyme 2 (ACE2)

Karen Liao, Daniel J. Sikkema, Catherine Wang et al. · Journal of Immunological Methods · 2013 · 23 citations

Life Sciences, Immunology, Pharmacology +14

Ibrutinib reprograms the glucocorticoid receptor in chronic lymphocytic leukemia cells

Yonghong Shi, Guizhi Wang, Elizabeth M. Muhowski et al. · Leukemia · 2019 · 11 citations

Life Sciences, Oncology, Pharmacology +11

1–4 of 4